OpenVSafe by OpenVAERS
Search V-safe

ARU-24411-27541

5 vaccinations 22 coded responses 38 check-ins 20 free-text entries 6 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
494 / MI
Registered
2021-03-17
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1704632 (opens in a new window) low 10 / 11 10 3 of 7 VAERS symptoms same dose (2) MI matches 2021-03-17 / 2021-03-19 / 2021-09-16
received the same day as the last call
case 1011602

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-02-16
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-17
    Registered in v-safe
  3. 2021-03-17
    Dose 2 — Pfizer-BioNTech
  4. 2021-03-17
    Survey response — day 0, dose 2
    MedDRA: Joint stiffness — Feeling: Fair · Fever · Chills, Joint pains · Be unable to do your normal daily activities
    Free text: Stiff jaw
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Joint stiffness, Lymphadenopathy, Musculoskeletal stiffness — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Free text: Stiff jaw and neck, swollen lymph node, all left side
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: Joint stiffness — Feeling: Good · Fatigue or tiredness
    Free text: No jaw stiffness, No swollen lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-21
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Oropharyngeal pain — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Sore throat and swollen lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-03-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Oropharyngeal pain — Feeling: Fair · Fever · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Free text: Swollen lymph nodes, sore throat
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Headache
    Adult check-in
  10. 2021-03-24
    Health check-in — day 7, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  11. 2021-03-31
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-04-07
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-04-14
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-04-21
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-04-28
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-06-16
    Survey response — 3 months, dose 2
    MedDRA: Conjunctivitis, Eye irritation, Fatigue, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Eye irritations just recently re-diagnosed as Pink Eye and some fatigue. · Healthcare visit (other): Outpatient Eye Clinic
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-06-16
    Report sent to call center — 3 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  18. 2021-06-28
  19. 2021-09-15
    Survey response — 6 months, dose 2
    MedDRA: Dermatitis contact, Eye disorder, Inflammation, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: I am having ongoing problems with my eyes..requiring steroid drops and have had the worst case of poison Ivy Ive ever had requiring 2 courses of prednisone. ALL issues related to some kind of inflammation and NOT typical for me :/ · Healthcare visit (other): Ophthalmology appointments
    MedDRA releases: 2024-11 · check-in free text available
  20. 2021-09-15
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    1 call case(s)
  21. 2021-09-16
    Call successful
    Completed over the phone
  22. 2021-10-08
    Dose 3 — Pfizer-BioNTech
  23. 2022-03-17
    Survey response — 12 months, dose 2
    MedDRA: Eye disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: I have had ongoing problems with my eyes, requiring prescription eye drops..but otherwise I have been great.
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-03-17
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  25. 2022-03-19
    Call successful
    Does not wish to fill out VAERS report
  26. 2022-05-04
    Dose 4 — Pfizer-BioNTech
  27. 2022-05-06
    Survey response — days 1–6 daily, dose 4
    MedDRA: Vision blurred — Feeling: Good · Chills, Headache
    Free text: Blurry vision
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-05-07
    Survey response — days 1–6 daily, dose 4
    MedDRA: Vision blurred — Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Free text: Blurry vision
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-05-08
    Survey response — days 1–6 daily, dose 4
    MedDRA: Vision blurred — Feeling: Good · Fatigue or tiredness
    Free text: Blurry vision
    MedDRA releases: 2024-11 · check-in free text available
  30. 2022-05-09
    Survey response — days 1–6 daily, dose 4
    MedDRA: Vision blurred — Feeling: Fair · Chills, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Blurry vision
    MedDRA releases: 2024-11 · check-in free text available
  31. 2022-05-10
    Survey response — days 1–6 daily, dose 4
    MedDRA: Vision blurred — Feeling: Good
    Free text: Slight blurry vision
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-05-11
    Survey response — day 7, dose 4
    MedDRA: Vision blurred — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activities
    Free text: Slight blurry vision
    MedDRA releases: 2024-11 · check-in free text available
  33. 2022-05-18
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  34. 2022-05-25
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  35. 2022-06-01
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  36. 2022-06-09
    Health check-in — day 35, dose 4
    Feeling: Fair
    Adult check-in
  37. 2022-06-15
    Survey response — day 42, dose 4
    MedDRA: Dry eye, Office visit, Vision blurred — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: I have had a continued and worsening problem with dry eye/blurry vision since receiving the Covid vaccinations. I don't know if this problem is related but I did not have it before. It is a profound difference but I am otherwise well. · Healthcare visit (other): Ophthalmologist
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-06-15
    Report sent to call center — day 42, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  39. 2022-06-16
    Call successful
    Participant prefers to complete VAERS report online
  40. 2022-08-03
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  41. 2022-10-03
    Dose 5 — Pfizer-BioNTech
    Co-administered: Flu
  42. 2022-10-06
    Survey response — days 1–6 daily, dose 5
    MedDRA: No adverse event — Feeling: Fair · Site: Pain · Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Free text:
    MedDRA releases: 2024-11 · check-in free text available
  43. 2022-10-07
    Survey response — days 1–6 daily, dose 5
    MedDRA: Vision blurred — Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Free text: Blurry vision
    MedDRA releases: 2024-11 · check-in free text available
  44. 2022-10-09
    Health check-in — days 1–6 daily, dose 5
    Feeling: Good · None
    Adult check-in
  45. 2022-10-10
    Health check-in — day 7, dose 5
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  46. 2022-10-17
    Survey response — day 14, dose 5
    MedDRA: Chills, Headache, Oropharyngeal pain, Pain, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Might be getting a head cold..headache/alt. Sore throat/chills/aches..did home test..neg. For Covid-19
    MedDRA releases: 2024-11 · check-in free text available
  47. 2022-10-24
    Health check-in — day 21, dose 5
    Feeling: Good
    Adult check-in
  48. 2022-10-31
    Survey response — day 28, dose 5
    MedDRA: Asthma — Feeling: Good · Be unable to do your normal daily activities
    Free text: Asthma episode
    MedDRA releases: 2024-11 · check-in free text available
  49. 2022-11-07
    Survey response — day 35, dose 5
    MedDRA: Asthma, Pain — Feeling: Fair · Be unable to do your normal daily activities
    Free text: body aches and asthma
    MedDRA releases: 2024-11 · check-in free text available
  50. 2022-11-14
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  51. 2023-01-02
    Survey response — 3 months, dose 5
    MedDRA: Asthma, Pre-existing disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  52. 2023-01-02
    Report sent to call center — 3 months, dose 5
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  53. 2023-01-04
    Call successful
    Not applicable - Accidental Reporting
  54. 2023-04-05
    Survey response — 6 months, dose 5
    MedDRA: Chemotherapy, Ovarian cancer stage IV — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    MedDRA releases: 2024-11
  55. 2023-04-05
    Report sent to call center — 6 months, dose 5
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  56. 2023-04-06
  57. 2023-04-11
  58. 2023-04-21
  59. 2023-04-21
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-02-16Pfizer-BioNTech
22021-03-17Pfizer-BioNTech
32021-10-08Pfizer-BioNTech No
42022-05-04Pfizer-BioNTech No
52022-10-03Pfizer-BioNTech Flu

Call center

6 call center cases

6 successful

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 5 — day 0, dose 2

2021-03-17

Systemic reaction (other): Stiff jaw

Release 5 — days 1–6 daily, dose 2

2021-03-18

Systemic reaction (other): Stiff jaw and neck, swollen lymph node, all left side

2021-03-19

Systemic reaction (other): No jaw stiffness, No swollen lymph nodes

Release 6 — days 1–6 daily, dose 2

2021-03-21

Systemic reaction (other): Sore throat and swollen lymph nodes

2021-03-22

Systemic reaction (other): Swollen lymph nodes, sore throat

Release 9 — 3 months, dose 2

2021-06-16

Symptoms: Eye irritations just recently re-diagnosed as Pink Eye and some fatigue.
Healthcare visit (other): Outpatient Eye Clinic

Release 9 — 6 months, dose 2

2021-09-15

Symptoms: I am having ongoing problems with my eyes..requiring steroid drops and have had the worst case of poison Ivy Ive ever had requiring 2 courses of prednisone. ALL issues related to some kind of inflammation and NOT typical for me :/
Healthcare visit (other): Ophthalmology appointments

Release 11 — 12 months, dose 2

2022-03-17

Symptoms: I have had ongoing problems with my eyes, requiring prescription eye drops..but otherwise I have been great.

Release 11 — days 1–6 daily, dose 4

2022-05-06

Systemic reaction (other): Blurry vision

2022-05-07

Systemic reaction (other): Blurry vision

2022-05-08

Systemic reaction (other): Blurry vision

2022-05-09

Systemic reaction (other): Blurry vision

2022-05-10

Systemic reaction (other): Slight blurry vision

Release 11 — day 7, dose 4

2022-05-11

Systemic reaction (other): Slight blurry vision

Release 12 — day 42, dose 4

2022-06-15

Symptoms: I have had a continued and worsening problem with dry eye/blurry vision since receiving the Covid vaccinations. I don't know if this problem is related but I did not have it before. It is a profound difference but I am otherwise well.
Healthcare visit (other): Ophthalmologist

Release 12 — days 1–6 daily, dose 5

2022-10-06


2022-10-07

Systemic reaction (other): Blurry vision

Release 12 — day 14, dose 5

2022-10-17

Symptoms: Might be getting a head cold..headache/alt. Sore throat/chills/aches..did home test..neg. For Covid-19

Release 12 — day 28, dose 5

2022-10-31

Symptoms: Asthma episode

Release 12 — day 35, dose 5

2022-11-07

Symptoms: body aches and asthma

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOChemotherapy · · ✓
HCVOOffice visit ✓ ✓ ✓
SDAsthma · · ✓
SDChills · · ✓
SDConjunctivitis ✓ ✓ ✓
SDDermatitis contact · · ✓
SDDry eye · · ✓
SDEye disorder · · ✓
SDEye irritation ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache · · ✓
SDInflammation · · ✓
SDOropharyngeal pain · · ✓
SDOvarian cancer stage IV · · ✓
SDPain · · ✓
SDPre-existing disease · · ✓
SDSARS-CoV-2 test negative · · ✓
SDVision blurred · · ✓
SROJoint stiffness ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROMusculoskeletal stiffness ✓ ✓ ✓
SRONo adverse event · · ✓
SROOropharyngeal pain ✓ ✓ ✓
SROVision blurred · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release